Related Experiment Videos
Haemostatic and lipid abnormalities in hypothyroidism.
Scandinavian Journal of Haematology
|February 1, 1976
Summary
Hypothyroidism is linked to abnormal blood lipid and clotting parameters. Thyroxin replacement therapy effectively corrected these hematologic abnormalities in 10 patients.
Area of Science:
- Endocrinology
- Hematology
- Biochemistry
Background:
- Hypothyroidism is associated with various metabolic disturbances.
- Previous studies suggest potential links between thyroid dysfunction and hemostatic abnormalities.
Purpose of the Study:
- To investigate the impact of hypothyroidism on plasma lipid profiles and hemostatic parameters.
- To evaluate the efficacy of thyroxin replacement therapy in correcting these abnormalities.
Main Methods:
- Observational study of 10 hypothyroid patients before and 3 months after thyroxin treatment.
- Assessed plasma levels of total cholesterol, phospholipids, and triglycerides.
- Evaluated bleeding time, activated partial thromboplastin time, recalcification time, and platelet factor 3 activity.
Main Results:
- All patients exhibited elevated plasma total cholesterol and phospholipids; 5 also had hypertriglyceridemia.
- Prolonged bleeding time, activated partial thromboplastin time, and recalcification time were observed.
- Reduced platelet factor 3 activity and lower platelet phospholipid and protein concentrations were noted.
- No significant correlation was found between lipid and hemostatic parameters.
Conclusions:
- Hypothyroidism is associated with significant lipid and hemostatic abnormalities.
- These abnormalities appear to be independent phenomena.
- Thyroxin replacement therapy effectively normalized all measured parameters, underscoring the crucial role of thyroid hormones in hemostasis and lipid metabolism.